Donnatal Extentabs®
"Donnatal Extentabs — time-release, balanced combination antispasmodic with mild calming effect. Effective relief of cramping and diarrhea; well tolerated:
- Dosage: 1 Extentab po bid or tid. Contains 0.3111 mg hyoscyamine, 0.0582 mg atropine, 0.0195 mg scopolamine and 48.6 mg Phenobarbital
- Extentabs are designed to release the ingredients gradually to provide effects for up to 12 hours" (1)
An Extended History of Trust
PBM Pharmaceuticals acquired the rights to Donnatal® products from Wyeth Laboratories in 2001. Following the acquisition, the response from
the medical community and IBS patients for Donnatal Extentabs® was overwhelming.
Both physicians and patients contacted
PBM, expressing their appreciation for maintaining Donnatal Extentabs® in the marketplace.
All Day, All Night... Donnatal Extentabs®
Donnatal Extentabs® are an extended release, combination antispasmodic therapy with a history of
trust for nearly 30 years.
More than 40,000 patient days per year have been prescribed by physicians in the antispasmodic category of therapy since 1991. (2)
Of all the options available in this type of therapy, only Donnatal Extentabs® provide gradual dissolution over 12 hours,
distinctively longer than immediate release tablets. (3)
The Benefits of Extended Release
The nighttime benefit afforded by extended release is important to IBS sufferers whose symptoms occurring through the night
prevent a full night's rest. Without proper rest at night, quality of life may be affected as well as the
ability to be productive in school or in the workplace.
Physicians have a limited armamentarium of drug products to treat Irritable Bowel Syndrome symptoms. It is essential that twice daily dosing products with a history of trust
be available for your prescribing. Donnatal Extentabs® is such a product and
deserves your consideration.
Donntal Extentabs® has an extended history of trust among physicians because of its extensive, documented long-term patient safety record. A trusted adjunctive therapy by gastroenterologists and other physicians for nearly 30 years, Donnatal Extentabs® afford patient convenience
on a 12-hour dosing schedule.
1)Engstrom, PF, Goosenberg, EB. Diagnosis and Management of Bowel Diseases, Second Edition, 2003; 6: 83.
2) Source Prescription Audit (SPA), Verispan, November 2002.
3) Data on File, PBM Pharmaceuticals.
|
